To determine whether peptide 60031 originates from intracellular processing of the SOX2 protein and is presented on the surface of tumour cells, the peptide-specific T cells were tested against the HLA-A2-positive glioma cell lines U343 and U373 expressing SOX2. The gene discussed is SOX2; the disease is central nervous system cancer.